During the past decade, UNC Kittner Eye Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 9 clinical trials were completed, i.e. on average, 81.8% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UNC Kittner Eye Center" #1 sponsor was "University of North Carolina, Chapel Hill" with 4 trials, followed by "Jaeb Center for Health Research" with 3 trials sponsored, "ForSight Vision5, Inc." with 2 trials sponsored, "Duke University" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UNC Kittner Eye Center" #1 collaborator was "National Eye Institute (NEI)" with 3 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "American Glaucoma Society" with 1 trials as a collaborator and "IQVIA Biotech" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "UNC Kittner Eye Center" are "Ocular Hypertension" (3 trials), "Diabetic Macular Edema" (2 trials), "Diabetic Retinopathy" (2 trials), "Primary Open-Angle Glaucoma" (2 trials) and "Cataract" (1 trials). Many other conditions were trialed in "UNC Kittner Eye Center" in a lesser frequency.

Most popular intervention types in "UNC Kittner Eye Center" are "Drug" (6 trials), "Device" (4 trials), "Procedure" (4 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bimatoprost" (2 trials), "0.67% Sodium Chloride Ophthalmic Solution" (1 trials), "2-mg Intravitreous Aflibercept Injection" (1 trials), "Ahmed Model FP7 Flexible Plate" (1 trials) and "Baerveldt Glaucoma Implant 250-mm2 / BG103-250" (1 trials). Other intervention names were less common.

The vast majority of trials in "UNC Kittner Eye Center" are 15 trials for "All" genders.

Currently, there are NaN active trials in "UNC Kittner Eye Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in UNC Kittner Eye Center, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in UNC Kittner Eye Center, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".